Recent developments in the histological diagnosis of spindle cell carcinoma, fibromatosis and phyllodes tumour of the breast

Histopathology

Volumn 52, Issue 1, 2008, Pages 45-57

  Lee, A H S ^a  

^a NOTTINGHAM CITY HOSPITAL   (United Kingdom)

Author keywords

Breast; Diagnosis; Fibromatosis; Metaplastic carcinoma; Needle biopsy; Phyllodes tumour; Spindle cell carcinoma

Indexed keywords

BETA CATENIN; CYTOKERATIN; CYTOKERATIN 14; CYTOKERATIN 5; CYTOKERATIN 7;

BIOLOGY; BREAST TUMOR; CANCER INVASION; CANCER RECURRENCE; CANCER SURVIVAL; CD34 SELECTION; CYSTOSARCOMA PHYLLOIDES; DIFFERENTIAL DIAGNOSIS; FIBROMATOSIS; HISTOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; METASTASIS; NEEDLE BIOPSY; PATHOPHYSIOLOGY; PERIDUCTAL STROMAL TUMOR; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SPINDLE CELL CARCINOMA; TUMOR; TUMOR DIAGNOSIS;

ANTIGENS, CD34; BREAST NEOPLASMS; CARCINOMA; DIAGNOSIS, DIFFERENTIAL; FEMALE; FIBROMA; HUMANS; PHYLLODES TUMOR;

PHYLLODES;

EID: 37249020063     PISSN: 03090167     EISSN: 13652559     Source Type: Journal    
DOI: 10.1111/j.1365-2559.2007.02893.x     Document Type: Review

References (75)

1. Khan HN, Wyld L, Dunne B et al. Spindle cell carcinoma of the breast: a case series of a rare histological subtype. Eur. J. Surg. Oncol. 2003 29 600 603.
2. Beatty JD, Atwood M, Tickman R, Reiner M. Metaplastic breast cancer: clinical significance. Am. J. Surg. 2006 191 657 664.
3. Wargotz ES, Norris HJ. Metaplastic carcinomas of the breast. III. Carcinosarcoma. Cancer 1989 64 1490 1499.
4. Lien HC, Lin CW, Mao TL, Kuo SH, Hsiao CH, Huang CS. p53 overexpression and mutation in metaplastic carcinoma of the breast: genetic evidence for a monoclonal origin of both the carcinomatous and the heterogeneous sarcomatous components. J. Pathol. 2004 204 131 139.
5. Kung FYL, Tse GMK, Lo KW, Law BKB, Chang AR, Chen MH. Metachronous bilateral mammary metaplastic and infiltrating duct carcinomas: a molecular study for clonality. Hum. Pathol. 2002 33 677 679.
6. Gobbi H, Simpson JF, Borowsky A, Jensen RA, Page DL. Metaplastic breast tumors with a dominant fibromatosis-like phenotype have a high risk of local recurrence. Cancer 1999 85 2170 2182.
7. Sneige N, Yaziji H, Mandavilli SR et al. Low-grade (fibromatosis-like) spindle cell carcinoma of the breast. Am. J. Surg. Pathol. 2001 25 1009 1016.
8. Denley H, Pinder SE, Tan PH et al. Metaplastic carcinoma of the breast arising within complex sclerosing lesion: a report of five cases. Histopathology 2000 36 203 209.
9. Gobbi H, Simpson JF, Jensen RA, Olson SJ, Page DL. Metaplastic spindle cell breast tumors arising within papillomas, complex sclerosing lesions, and nipple adenomas. Mod. Pathol. 2003 16 893 901.
10. Dunne B, Lee AHS, Pinder SE, Bell JA, Ellis IO. An Immunohistochemical study of metaplastic spindle cell carcinoma, phyllodes tumor and fibromatosis of the breast. Hum. Pathol. 2003 34 1009 1015.
11. Leibl S, Gogg-Kammerer M, Sommersacher A, Denk H, Moinfar F. Metaplastic breast carcinomas: are they of myoepithelial differentiation?: immunohistochemical profile of the sarcomatoid subtype using novel myoepithelial markers. Am. J. Surg. Pathol. 2005 29 347 353.
12. Carter MR, Hornick JL, Lester S, Fletcher CDM. Spindle cell (sarcomatoid) carcinoma of the breast: a clinicopathologic and immunohistochemical analysis of 29 cases. Am. J. Surg. Pathol. 2006 30 300 309.
13. Reis-Filho JS, Milanezi F, Steele D et al. Metaplastic breast carcinomas are basal-like tumours. Histopathology 2006 49 10 21.
14. Lee AHS. The histological diagnosis of metastases to the breast from extramammary malignancies. J. Clin. Pathol. 2007 in press).
15. Khanafshar E, Phillipson J, Schammel DP, Minobe L, Cymerman J, Weidner N. Inflammatory myofibroblastic tumor of the breast. Ann. Diagn. Pathol. 2005 9 123 129.
16. Fletcher CDM. Soft tissue tumors. In Fletcher CDM ed. Diagnostic histopathology of tumors, 3rd Edition. Edinburgh : Churchill Livingstone, 2007 1527 1592.
17. Koker MM, Kleer CG. p63 expression in breast cancer: a highly sensitive and specific marker of metaplastic carcinoma. Am. J. Surg. Pathol. 2004 28 1506 1512.
18. Leibl S, Moinfar F. Mammary NOS-type sarcoma with CD10 expression: a rare entity with features of myoepithelial differentiation. Am. J. Surg. Pathol. 2006 30 450 456.
19. Reis-Filho JS, Simpson PT, Martins A, Preto A, Gartner F, Schmitt FC. Distribution of p63, cytokeratins 5/6 and cytokeratin 14 in 51 normal and 400 neoplastic human tissue samples using TARP-4 multi-tumor tissue microarray. Virchows Arch. 2003 443 122 132.
20. Wargotz ES, Deos PH, Norris HJ. Metaplastic carcinomas of the breast. II. Spindle cell carcinoma. Hum. Pathol. 1989 20 732 740.
21. Leibl S, Moinfar F. Metaplastic breast carcinomas are negative for Her-2 but frequently express EGFR (Her-1): potential relevance to adjuvant treatment with EGFR tyrosine kinase inhibitors? J. Clin. Pathol. 2005 58 700 704.
22. Tse GM, Tan PH, Putti TC, Lui PCW, Chaiwun B, Law BKB. Metaplastic carcinoma of the breast: a clinicopathological review. J. Clin. Pathol. 2006 59 1079 1083.
23. Rakha EA, Putti TC, Abd El-Rehim DM et al. Morphological and immunophenotypic analysis of breast carcinomas with basal and myoepithelial differentiation. J. Pathol. 2006 208 495 506.
24. Christensen L, Schiodt T, Blichert-Toft M. Sarcomatoid tumours of the breast in Denmark from 1977 to 1987. A clinicopathological and immunohistochemical study of 100 cases. Eur. J. Cancer 1993 29A 1824 1831.
25. Moore T, Lee AHS. Expression of CD34 and bcl-2 in phyllodes tumours, fibroadenomas and spindle cell lesions of the breast. Histopathology 2001 38 62 67.
26. Damera A, Evans AJ, Cornford EJ et al. Diagnosis of axillary nodal metastases by ultrasound-guided core biopsy in primary operable breast cancer. Br. J. Cancer 2003 89 1310 1313.
27. Wargotz ES, Norris HJ, Austin RM, Enzinger FM. Fibromatosis of the breast. A clinical and pathological study of 28 cases. Am. J. Surg. Pathol. 1987 11 38 45.
28. Rosen PP, Ernsberger D. Mammary fibromatosis. A benign spindle-cell tumor with significant risk for local recurrence. Cancer 1989 63 1363 1369.
29. Devouassoux-Shisheboran M, Schammel MD, Man YG, Tavassoli FA. Fibromatosis of the breast: age-correlated morphofunctional features of 33 cases. Arch. Pathol. Lab. Med. 2000 124 276 280.
30. Abraham SC, Reynolds C, Lee JH et al. Fibromatosis of the breast and mutations involving the APC/β-catenin pathway. (Erratum in: Hum Pathol 2002; 33; 379.). Hum. Pathol. 2002 33 39 46.
31. Sawyer EJ, Hanby AM, Rowan AJ et al. The Wnt pathway, epithelial-stromal interactions, and malignant progression in phyllodes tumours. J. Pathol. 2002 196 437 444.
32. Sawyer EJ, Hanby AM, Poulsom R et al. Beta-catenin abnormalities and associated insulin-like growth factor overexpression are important in phyllodes tumours and fibroadenomas of the breast. J. Pathol. 2003 200 627 632.
33. Foxcroft LM, Evans EB, Porter AJ. Difficulties in the pre-operative diagnosis of phyllodes tumours of the breast: a study of 84 cases. Breast 2007 16 27 37.
34. Shimizu K, Masawa N, Yamada T, Okamoto K, Kanda K. Cytologic evaluation of phyllodes tumors as compared to fibroadenomas of the breast. Acta Cytol. 1994 38 891 897.
35. Tse GMK, Ma TKF, Pang LM, Cheung H. Fine needle aspiration cytologic features of mammary phyllodes tumors. Acta Cytol. 2002 46 855 863.
36. Komenaka IK, El-Tamer M, Pile-Spellman E, Hibshoosh H. Core needle biopsy as a diagnostic tool to differentiate phyllodes tumor from fibroadenoma. Arch. Surg. 2003 138 987 990.
37. Jacobs TW, Chen YY, Guinee DG et al. Fibroepithelial lesions with cellular stroma on breast core needle biopsy: are there predictors of outcome on surgical excision? Am. J. Clin. Pathol. 2005 124 342 354.
38. Dillon MF, Quinn CM, McDermott EW, O'Doherty A, O'Higgins N, Hill ADK. Needle core biopsy in the diagnosis of phyllodes neoplasm. Surgery 2006 140 779 784.
39. Lee AHS, Hodi Z, Ellis IO, Elston CW. Histological features useful in the distinction of phyllodes tumour and fibroadenoma on needle core biopsy of the breast. Histopathology 2007 51 336 344.
40. Kocova L, Skalova A, Fakan F, Rousarova M. Phyllodes tumour of the breast: immunohistochemical study of 37 tumours using MIB1 antibody. Pathol. Res. Pract. 1998 194 97 104.
41. Umekita Y, Yoshida H. Immunohistochemical study of MIB1 expression in phyllodes tumor and fibroadenoma. Pathol. Int. 1999 49 807 810.
42. Rajan PB, Cranor ML, Rosen PP. Cystosarcoma phyllodes in adolescent girls and young women: a study of 45 patients. Am. J. Surg. Pathol. 1998 22 64 69.
43. Yilmaz E, Sal S, Lebe B. Differentiation of phyllodes tumors versus fibroadenomas. Mammographic and sonographic features. Acta Radiol. 2002 43 34 39.
44. Chao TC, Lo YF, Chen SC, Chen MF. Sonographic features of phyllodes tumors of the breast. Ultrasound Obstet. Gynecol. 2002 20 64 71.
45. Evans AJ, Wilson ARM, Blamey RW, Robertson JFR, Ellis IO, Elston CW. Phyllodes tumour. In Atlas of breast disease management: 50 illustrative cases. London : W B Saunders, 1998 69 70.
46. Noguchi S, Motomura K, Inaji H, Imaoka S, Koyama H. Clonal analysis of fibroadenoma and phyllodes tumor of the breast. Cancer Res. 1993 53 4071 4074.
47. Noguchi S, Yokouchi H, Aihara T et al. Progression of fibroadenoma to phyllodes tumor demonstrated by clonal analysis. Cancer 1995 76 1779 1785.
48. Kuijper A, Buerger H, Simon R et al. Analysis of the progression of fibroepithelial tumours of the breast by PCR-based clonality assay. J. Pathol. 2002 197 575 581.
49. Sawyer EJ, Hanby AM, Ellis P et al. Molecular analysis of phyllodes tumors reveals distinct changes in the epithelial and stromal components. Am. J. Pathol. 2000 156 1093 1098.
50. Tse GMK, Lee CS, Kung FYL et al. Hormonal receptors expression in epithelial cells of mammary phyllodes tumors correlates with pathologic grade of the tumor: a multicenter study of 143 cases. Am. J. Clin. Pathol. 2002 118 522 526.
51. Kracht J, Sapino A, Bussolati G. Malignant phyllodes tumor of breast with lung metastases mimicking the primary. Am. J. Surg. Pathol. 1998 22 1284 1290.
52. Lae M, Vincent-Salomon A, Savignoni A et al. Phyllodes tumors of the breast segregate in two groups according to genetic criteria. Mod. Pathol. 2007 20 435 444.
53. Jee KJ, Gong G, Ahn SH, Park JM, Knuutila S. Gain in 1q is a common abnormality in phyllodes tumours of the breast. Anal Cellular Pathol 2003 25 89 93.
54. Tse GMK, Putti TC, Kung FYL et al. Increased p53 protein expression in malignant mammary phyllodes tumors. Mod. Pathol. 2002 15 734 740.
55. Tan PH, Jayabaskar T, Yip G et al. p53 and c-kit (CD117) protein expression as prognostic indicators in breast phyllodes tumors: a tissue microarray study. Mod. Pathol. 2005 18 1527 1534.
56. Birch JM, Alston RD, McNally RJQ et al. Relative frequency and morphology of cancers in carriers of germline TP53 mutations. Oncogene 2001 20 4621 4628.
57. Sawyer EJ, Poulsom R, Hunt FT et al. Malignant phyllodes tumours show stromal overexpression of c-myc and c-kit. J. Pathol. 2003 200 59 64.
58. Carvalho S, e Silva AO, Milanezi F et al. c-KIT and PDGFRA in breast phyllodes tumours: overexpression without mutations? J. Clin. Pathol. 2004 57 1075 1079.
59. Kersting C, Kuijper A, Schmidt H et al. Amplifications of the epidermal growth factor receptor gene (egfr) are common in phyllodes tumors of the breast and are associated with tumor progression. Lab. Invest. 2006 86 54 61.
60. Elston CW, Ellis IO. Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. Histopathology 1991 19 403 410.
61. Moffat CJC, Pinder SE, Dixon AR, Elston CW, Blamey RW, Ellis IO. Phyllodes tumours of the breast: a clinicopathological review of thirty-two cases. Histopathology 1995 27 205 218.
62. de Roos WK, Kaye P, Dent DM. Factors leading to local recurrence or death after surgical resection of phyllodes tumours of the breast. Br. J. Surg. 1999 86 396 399.
63. Chen WH, Cheng SP, Tzen CY et al. Surgical treatment of phyllodes tumors of the breast: retrospective review of 172 cases. J. Surg. Oncol. 2005 91 185 194.
64. Tan PH, Jayabaskar T, Chuah KL et al. Phyllodes tumors of the breast: the role of pathologic parameters. Am. J. Clin. Pathol. 2005 123 529 540.
65. Ben Hassouna J, Damak T, Gamoudi A et al. Phyllodes tumors of the breast: a case series of 106 patients. Am. J. Surg. 2006 192 141 147.
66. Chaney AW, Pollack A, McNeese MD et al. Primary treatment of cystosarcoma phyllodes of the breast. Cancer 2000 89 1502 1511.
67. Reinfuss M, Mitu J, Duda K, Stelmach A, Rys J, Smolak K. The treatment and prognosis of patients with phyllodes tumor of the breast: an analysis of 170 cases. Cancer 1996 77 910 916.
68. Barth RJ. Histologic features predict local recurrence after breast conserving therapy of phyllodes tumors. Breast Cancer Res. Treat. 1999 57 291 295.
69. Kapiris I, Nasiri N, A'Hern R, Healy V, Gui GPH. Outcome and predictive factors of local recurrence and distant metastases following primary surgical treatment of high-grade malignant phyllodes tumours of the breast. Eur. J. Surg. Oncol. 2001 27 723 730.
70. Zurrida S, Bartoli C, Galimberti V et al. Which therapy for unexpected phyllode tumour of the breast? Eur. J. Cancer 1992 28 654 657.
71. Parker SJ, Harries SA. Phyllodes tumours. Postgrad. Med. J. 2001 77 428 435.
72. Reinfuss M, Mitu J, Smolak K, Stelmach A. Malignant phyllodes tumours of the breast. A clinical and pathological analysis of 55 cases. Eur. J. Cancer 1993 29A 1252 1256.
73. Asoglu O, Ugurlu MM, Blanchard K et al. Risk factors for recurrence and death after primary surgical treatment of malignant phyllodes tumors. Ann. Surg. Oncol. 2004 11 1011 1017.
74. Powell CM, Rosen PP. Adipose differentiation in cystosarcoma phyllodes: a study of 14 cases. Am. J. Surg. Pathol. 1994 18 720 727.
75. Burga AM, Tavassoli FA. Periductal stromal tumor: a rare lesion with low-grade sarcomatous behavior. Am. J. Surg. Pathol. 2003 27 343 348.